Conference Description

October 15, 2005
Wyndham Westshore Hotel
4860 West Kennedy Boulevard
Tampa, FL 33609
(813) 286-4400

Tell a friend about this conference
Download the brochure for this conference.
See how attendees evaluated this conference.

CME Credits 7.25*

Nonrefundable registration fee: $0.

Target Audience: Physicians, Nurse Practitioners, and Physician Assistants.

Program Summary:
This program will provide Primary Care Physicians the opportunity to learn first hand from national thought leaders in their field. The goal is to provide a clearer understanding of several of the most common disease processes, in light of rapid scientific advances. By doing so, attendees will walk away with new insights and learn useful strategies to manage the challenges faced on a daily basis.

Learning Objectives:
At the conclusion of this CME activity, the participant will be able to:

1. understand basic concepts of how intravascular ultrasound has changed our understanding of atherosclerosis progression and utilize latest statin trial data to promote disease regression and decrease clinical events
2. utilize latest strategies to effectively manage patients with various forms of heart failure
3. evaluate, stage and manage patients with chronic kidney disease
4. understand the mechanisms and advantages of multiple hormonal control in glucose metabolism, and the role of “incretin mimetics” and “incretin enhancers” in the management of type 2 diabetes
5. recognize, diagnose and treat Non-Alcoholic Steatohepatitis
6. more effectively assess the severity of disease in patients with COPD and formulate an effective therapeutic approach based on physiology of disease and the patient’s quality of life
7. more effectively minimize practice liability exposure, structure the practice environment in an efficient and productive manner, and assess different strategies for acquisition

Agenda:

7:30-8:10		Continental Breakfast and Registration
8:10-8:20		Welcome Remarks Gregg Sherman, MD
8:20-9:20		Aggressive Treatment of Coronary Artery Atherosclerosis: Is Regression Possible? Richard Kerensky, MD
9:20-10:20		Congestive Heart Failure in Primary Care; Has The Treatment Regimen Changed? Steven Cohen, MD
10:20-10:40		Break/Vendor Area
10:40-11:40		The Approach to the Patient with Chronic Kidney Disease Biff Palmer, MD
11:40-12:40		New Therapies for Treatment of Diabetes David Leonard, MD
12:40-1:30		Lunch
1:30-2:30		The Skinny on Fatty Liver Disease Stephen H. Caldwell, MD
2:30-3:30		COPD –A New Look at an Old Disease Bruce Krieger, MD
3:30-3:50		Break/Vendor Area
3:50-4:50		Practice and Risk Management in 2005 Stuart R. Morris, CPA, Esq.
4:50–5:00		Conference Wrap Up Gregg Sherman, MD

Faculty:
Stephen H. Caldwell, MD
Director of Hepatology
Associate Professor of Internal Medicine
University of Virginia, Charlottesville, Virginia

Steven Cohen, MD
Chief of Congestive Heart Failure
Boca Raton Community Hospital
Boca Raton, Florida

Richard Kerensky, MD
Associate Professor of Medicine
Director of Cardiac Catheterization Lab
Director of Interventional Cardiology
Shands Hospital University of Florida

Bruce Krieger, MD
Professor of Medicine (voluntary)
Miller School of Medicine,
University of Miami, Miami, Florida

David Leonard, MD
Medical Director /Director of Research
Joslin Diabetes Center at Morton Plant Hospital
Clinical Assistant Professor of Medicine,
University of South Florida, Tampa, Florida

Stuart R. Morris, CPA, Esq.
Board Certified in Wills, Trusts and Estates
Board Certified in Elder Law
Boca Raton, Florida

Biff Palmer, MD
Professor of Internal Medicine
Nephrology Fellowship Program Director
UT Southwestern Medical Center,
Dallas, Texas

Program Chair: Gregg Sherman, MD

Activity Director: Alan Goodstat, LCSW

*Continuing Education Information
This activity has been reviewed and is acceptable for up to 7.25 Prescribed credit hours by the American Academy of Family Physicians.

This program was supported through educational grants from the following companies: Amylin, Axcan Pharma, Boehringer Ingelheim, Novartis, Pfizer, sanofi-aventis, Takeda.